Patents by Inventor Elise Kohn

Elise Kohn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
    Publication number: 20210322415
    Abstract: Methods comprising repeating cycles of administration of a composition comprising cediranib according to a fixed intermittent dosing regimen comprising administration of an effective amount of the composition comprising cediranib on one or more consecutive days of a cycle followed by one or more consecutive days of rest on which said composition is not administered are disclosed herein, and may be used as monotherapy or may comprise administration of one or more partner drugs or therapies and may be used in combination therapy.
    Type: Application
    Filed: February 14, 2017
    Publication date: October 21, 2021
    Applicants: ASTRAZENECA AB, THE UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH AND HUMAN SERVICES
    Inventors: Simon BARRY, Jane KENDREW, Tony HO, Stephen Robert WEDGE, Susan Percy IVY, Elise KOHN, Jung-Min LEE
  • Method for treating taxol side-effects with G-CSF
    Patent number: 5496804
    Abstract: A method of treating a host using taxol comprising administering granulocyte colony-stimulating factor to the host being treated with taxol. The present inventive method allows for increased levels of taxol to be administered to the host in the treatment of various conditions, particularly with respect to ovarian tumors.
    Type: Grant
    Filed: November 21, 1994
    Date of Patent: March 5, 1996
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eddie Reed, Elise Kohn, Gisele Sarosy
  • Method for treating taxol side-effects with G-CSF
    Patent number: RE38424
    Abstract: A method of treating a host using taxol comprising administering granulocyte colony-stimulating factor to the host being treated with taxol. The present inventive method allows for increased levels of taxol to be administered to the host in the treatment of various conditions, particularly with respect to ovarian tumors.
    Type: Grant
    Filed: October 15, 1999
    Date of Patent: February 10, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Eddie Reed, Elise Kohn, Gisele Sarosy